Treatment for Ischemic Stroke: A New Approach from the AncientArt of War

The Pro-inflammatory Cytokine Interleukin-1β is a Key Regulatory Factor for the Postictal Suppression in Mice

(2015) An-Feng Tao et al.   CNS Neuroscience & Therapeutics

A Combination of Neostigmine and Anisodamine Protects against Ischemic Stroke by Activating α7nAChR

(2015) Jiao Qian et al.   International Journal of Stroke

Mechanisms and Potential Therapeutic Applications of Microglial Activation after Brain Injury

(2014) Jong-Youl Kim et al.   CNS Neuroscience & Therapeutics

Guidelines for the Primary Prevention of Stroke

(2014) James F. Meschia et al.   STROKE

Stroke Statistics in Korea: Part II Stroke Awareness and Acute Stroke Care, A Report from the Korean Stroke Society and Clinical Research Center For Stroke

(2013) Keun-Sik Hong et al.   Journal of Stroke

Combined administration of anisodamine and neostigmine produces anti-shock effects: involvement of α7 nicotinic acetylcholine receptors

(2012) Li Sun et al.   ACTA PHARMACOLOGICA SINICA

Involvement of Acetylcholine-α7nAChR in the Protective Effects of Arterial Baroreflex against Ischemic Stroke

(2012) Ai-Jun Liu et al.   CNS Neuroscience & Therapeutics

Neuronal oxidative stress in acute ischemic stroke: Sources and contribution to cell injury

(2012) Silvia Manzanero et al.   NEUROCHEMISTRY INTERNATIONAL

Antishock effect of anisodamine involves a novel pathway for activating α7 nicotinic acetylcholine receptor*

(2009) Chong Liu et al.   CRITICAL CARE MEDICINE

Mechanisms of Microglia-Mediated Neurotoxicity in a New Model of the Stroke Penumbra

(2008) V. Kaushal et al.   JOURNAL OF NEUROSCIENCE